Tekzima established in 2016 by a group of well experienced scientists. Tekzima thinks to a better services to the community and acts on principles of operational excellence to reach to its goals.

By Tekzima’s product, Beraksurf®, we change a lethal situation of some newborn infants into a new vital and controlled condition. We serve parents having newborns with Infant respiratory distress syndrome (IRDS), by presenting an effective treatment of the newborn with our product, Beraksurf® (Beractant).

We have serious commitment to our responsibilities against community, environment and all of our related people including investors and staff. Our values are transparent integrity in all of our responsibilities and achievements.